Brookfield Asset Management Ltd. (BAM)vsBlackRock Health Sciences Trust II (BMEZ)
BAM
Brookfield Asset Management Ltd.
$46.70
+1.09%
FINANCIAL SERVICES · Cap: $76.25B
BMEZ
BlackRock Health Sciences Trust II
$14.33
-0.97%
FINANCIAL SERVICES · Cap: $904.39M
Smart Verdict
WallStSmart Research — data-driven comparison
BAM leads profitability with a 49.7% profit margin vs 0.0%. BMEZ trades at a lower P/E of 5.7x. BAM earns a higher WallStSmart Score of 68/100 (B-).
BAM
Strong Buy68
out of 100
Grade: B-
BMEZ
Avoid30
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 33 in profit
Keeps 50 of every $100 in revenue as profit
Strong operational efficiency at 64.5%
Large-cap with strong market position
Revenue surging 23.8% year-over-year
Attractively priced relative to earnings
Conservative balance sheet, low leverage
Areas to Watch
Premium valuation, high expectations priced in
Trading at 9.9x book value
Grey zone — moderate risk
Weak financial health signals
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 5.7% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : BAM
The strongest argument for BAM centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 49.7% and operating margin at 64.5%. Revenue growth of 23.8% demonstrates continued momentum.
Bull Case : BMEZ
The strongest argument for BMEZ centers on P/E Ratio, Debt/Equity.
Bear Case : BAM
The primary concerns for BAM are P/E Ratio, Price/Book, Altman Z-Score.
Bear Case : BMEZ
The primary concerns for BMEZ are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
BAM profiles as a growth stock while BMEZ is a value play — different risk/reward profiles.
BAM is growing revenue faster at 23.8% — sustainability is the question.
BAM generates stronger free cash flow (339M), providing more financial flexibility.
Monitor ASSET MANAGEMENT industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BAM scores higher overall (68/100 vs 30/100), backed by strong 49.7% margins and 23.8% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Brookfield Asset Management Ltd.
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Brookfield Asset Management is a leading global alternative asset manager and one of the largest investors in real assets.
Visit Website →BlackRock Health Sciences Trust II
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
BlackRock Health Sciences Trust II (BMEZ) is a closed-end fund designed to deliver high total returns by investing in a diversified portfolio focused primarily on the health sciences sector, encompassing pharmaceuticals, biotechnology, and medical devices. Backed by BlackRock's extensive investment management experience, BMEZ seeks to capitalize on substantial growth prospects driven by demographic shifts and increasing healthcare spending. The fund's disciplined and strategic investment approach positions it as a compelling choice for institutional investors looking to enhance their portfolios while navigating the dynamic and innovative landscape of the health sciences industry.
Compare with Other ASSET MANAGEMENT Stocks
Want to dig deeper into these stocks?